Category: Claims handling · Reviewed by Al Jabbar, Broker · Specialist Risks · Last reviewed 2026-06-11
Aggregation of damages is the process of consolidating multiple separate damages claims arising from connected events into a single recoverable amount — distinct from coverage aggregation, which addresses the application of policy limits.
Damages aggregation operates at the substantive law level. Where a single underlying wrong causes multiple types of loss to multiple claimants, the law must decide whether those losses can all be recovered in a single action and from a single defendant. Aggregation rules govern joinder of claims, joinder of parties, group litigation orders and the treatment of interrelated losses.
This is distinct from coverage aggregation (the policy limit question) — but in practice the two interact. A defendant facing a single aggregated claim may have insurance that itself aggregates the loss as one claim, producing one limit; or the defendant may face multiple separate claims with multiple separate limits available.
The framework includes:
For mass-tort cases (asbestos, defective product, environmental, pension mis-selling), aggregation issues drive procedural strategy. A claimant pool of 1,000 affected individuals is materially different from 1,000 individual claims; the aggregated forum can produce efficiencies but also create coordination problems.
For commercial claims, aggregation is rarer but appears in supply-chain failures, IT-system failures and corporate-restructuring disputes affecting multiple counterparties.
Aggregation analysis proceeds through:
First, identify whether the multiple claims share common questions of law or fact such that they can sensibly be joined. The CPR 19.1 test focuses on common or related question.
Second, decide the appropriate procedural vehicle: joinder, consolidation, GLO, representative action or separate proceedings managed in parallel.
Third, plan disclosure and evidence consistently with the chosen vehicle. A GLO requires a common cause of action, common issues for determination, and lead claimants whose results inform the others.
Fourth, address apportionment between defendants if multiple defendants are involved. The Civil Liability (Contribution) Act 1978 governs.
Fifth, consider settlement architecture. Aggregated claims often settle through scheme-of-arrangement structures, mass settlements with opt-out mechanisms, or court-approved compromise schemes.
For insurance defendants, aggregated claims raise two questions: how does the underlying liability aggregate, and how does the policy coverage aggregate? Both are analytically separate but practically intertwined. The defendant’s insurance cover may aggregate the claims as a single claim under the policy wording (capping insurer exposure at one limit) while the underlying liability is not aggregated by the substantive law (preserving the defendant’s liability to each claimant individually).
This mismatch produces some of the most difficult insurance-coverage disputes. A defendant facing 200 underlying claims totalling £50m but with only £5m of aggregating insurance cover is left with a £45m self-insured exposure.
For class actions, the substantive aggregation rules in Lloyd v Google limited the use of representative actions for damages claims where individual losses are required to be proved. This has shaped the practical scope of mass-tort aggregation in data protection and competition law.
“Group Litigation Order” (CPR 19 Section II) — the principal procedural vehicle for multi-claimant aggregation.
“Representative action” (CPR 19.6) — used where the claimants share the same interest in the matter; narrower in scope post-Lloyd v Google.
“Consolidated proceedings” — where the court consolidates multiple separate proceedings into one, useful where the parties are different but the issues overlap.
“Test case” — where the parties or the court identify one claim to determine common issues that will apply to others.
“Settlement scheme” — a court-approved compromise structure binding all defined participants, used in mass-tort settlements.
A product-liability claim arises from a defective medical device implanted in approximately 2,400 UK patients between 2018 and 2022. A Group Litigation Order is sought under CPR Part 19 Section II. The court grants the GLO with the lead claimants’ issues identified: liability for design defect, liability for failure to warn, the application of the Consumer Protection Act 1987 limitation period, generic causation, and quantum methodology for the most common patient categories.
The defendant’s product liability policy is on the Lloyd’s market with an originating-cause aggregation clause. The defective design is held to be a single originating cause; all 2,400 claims aggregate as a single claim for policy purposes. The policy has £20m per claim and £40m aggregate. The defendant’s total exposure under the substantive law is approximately £140m on settled bands; the available insurance cover is £20m. The defendant is left with a £120m self-insured exposure.
The proceedings are managed under the GLO with lead claimants determined first; the remaining claims are settled by reference to the lead claimants’ outcomes through a structured settlement scheme.
By Matt Bartlett, Director, on 2026-06-11. Next review: 2026-12-11.
This entry is part of the Apex Insurance Wiki. Last reviewed by Matt Bartlett on 2026-06-11. Apex Insurance Brokers Limited, FCA FRN 724952, Companies House 07014570. Not regulated advice — consult your broker on your specific position.
Apex Insurance Brokers serves UK professional services firms and commercial businesses. Call 0117 325 0027, email hello@apexinsurancebrokers.co.uk, or request a quotation.
Get a quote